Skip to content
Increase font size Default font size Decrease font size
Product Pipeline

ProductClinical IndicationStatus
BC-819 Bladder Cancer Phase IIb
Ovarian Cancer Phase I/IIa

Pancreatic Cancer

Phase I/IIa
Liver Cancer Compassionate Use
Renal Pelvis TCC Compassionate Use
BC-820 Completed Pre-Clinical Development
BC-821 Completed Pre-Clinical Development
BC-822 (H19-siRNA) Completed Pre-Clinical Development
Sequential Undergoing Pre-Clinical Development